HomepeptideNAD+ and Related Peptides for Stimulant Load: Evidence on Repair Layers

Download

Evidence review

NAD+ and Related Peptides for Stimulant Load: Evidence on Repair Layers

Name: NAD+ and Related Peptides for Stimulant Load: Evidence on Repair Layers
Creator: miscsubjects
Published: 2026-06-29T21:32:44.696Z
Keywords: peptide, matrix

Posted Jun 29, 2026 · Updated Jul 17, 2026 · 4 min read

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `nad-plus-stimulants`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/nad-plus-stimulants

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/nad-plus-stimulants/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/nad-plus-stimulants/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/nad-plus-stimulants/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/nad-plus-stimulants/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Stimulant load (Adderall / amphetamine)

Amphetamines force dopamine and norepinephrine release. This borrows focus now.

Sleep, appetite, and gut lining often suffer. Less regeneration window follows.

Chronic load can deplete neurochemistry and stress the gut-brain axis.

Four layers show the mismatch between breakdown and repair:

Dopamine system: Forced release leads to depletion, crash, anhedonia, and tolerance.
Sleep: Stimulants delay onset and cut deep sleep stages.
Gut: Mucosa faces stress; inflammation feeds back to mood and cognition.
Anxiety: Arousal without calm produces jitter, rumination, and non-restorative stress.

Why Semax might help you

You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
What keeps failing: BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.
What Semax is studied to do: Studied for BDNF and neural support — building connections, not sedating symptoms.
Therefore for you: If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.

Why Selank might help you

You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
Layer breaking down: Anxiety — Arousal without calm leads to jitter, rumination, non-restorative stress.
What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.
Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.

Why DSIP might help you

You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
Layer breaking down: Sleep — Stimulants delay sleep onset and cut deep sleep.
What DSIP is studied to do: Studied for sleep architecture and deep-sleep promotion.
Therefore for you: If that layer is part of your problem, DSIP is discussed because it targets repair (sleep / repair window) — not because it masks pain.

Why NAD+ might help you

You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.

Why Amphetamine stimulants matters for you

Drug: Amphetamine stimulants.
What it does: Forces neurotransmitter release; borrows focus at cost of sleep/gut reserve.
Therefore for you: This drug suppresses signals of fatigue and suppresses repair windows. It trades short-term focus for longer-term depletion of neurochemistry and sleep architecture.

How these fit together

Neural support (Semax), non-benzo calm (Selank), sleep repair window (DSIP) — each targets a stimulant-degeneration layer.

Semax targets neural / cognitive.
Selank targets anxiety / neurochemistry.
DSIP targets sleep / repair window.
NAD+ targets cellular energy.

The stack maps distinct layers without overlap in primary action. Semax addresses BDNF and dopamine-related fatigue. Selank addresses arousal excess. DSIP widens the deep-sleep window stimulants shrink. NAD+ supports mitochondrial energy that stimulants can tax. Together they address separate points where breakdown exceeds repair.

What the evidence actually shows

Human data exist for Selank in generalized anxiety disorder. One trial compared it to medazepam in 62 patients and found comparable anxiolytic effects with additional cognitive benefits (source s12). Another small trial noted rapid response in some GAD patients (source s10).

Semax has animal data showing increased BDNF in rat basal forebrain and hippocampus after intranasal dosing (source s6, source s0). A hypothesis paper links this to potential ADHD relevance via dopamine and BDNF pathways (source s1). One Russian pediatric report mentioned in secondary sources noted behavioral improvements in half of ADHD cases, but no large Western RCT confirms this (source s3, source s5).

DSIP reduced amphetamine-induced hyperthermia in mice in one 1984 study (source s15). Human sleep studies are small and mixed; early trials reported increased delta sleep pressure in volunteers, yet results vary (source s16, source s18).

NAD+ shows preclinical mitochondrial support and some observational links to addiction recovery pathways (source s19). Small older human reports on intravenous NAD for substance issues exist but lack modern controls (source s21). No direct human trials tie NAD+ specifically to amphetamine recovery.

What scientists say

Researchers note Semax augments psychostimulant effects on dopamine in animals while raising BDNF (source s1). Selank trials emphasize GABAergic modulation without sedation (source s12). DSIP literature describes it as sleep-promoting rather than sedative (source s16). NAD+ reviews highlight its role in energy metabolism and potential in substance contexts, while calling for more controlled human data (source s19, source s20).

What people say on Reddit

Users report stacking Semax with Selank for focus and calm while on or after stimulants. Some describe improved task management and reduced jitter (source s29, source s32). DSIP threads mention deeper sleep perception. NAD+ appears in stacks for energy recovery but with variable subjective notes (source s33, source s34).

What people say on X

Limited direct posts in available data; discussions echo Reddit patterns on peptide stacks for stimulant side effects, often anecdotal.

What we do not know

No large-scale Western randomized controlled trials exist for any of these compounds specifically in stimulant recovery populations. Human evidence for Semax in ADHD remains limited to non-English or small datasets. DSIP and NAD+ human data for this exact context stay sparse or absent. Long-term safety and interaction profiles with ongoing amphetamine use lack dedicated study.

Safety and limits

All compounds discussed here carry limited regulatory approval outside specific regions. Evidence grades remain mostly preclinical or small human for anxiety/sleep indications. Individual responses vary. This article inventories published observations only.

PARTIAL 5/6 This page is a proof object. Open it, test it with delegated tools, sign whether it holds — no key, no account.

What is checked

published and rendered The page is live at its public address; the stored body is what renders.
claims extracted 5 claims are extracted and stored on the object.
sources open 7 sources are registered on the object; each opens from the page.
claims bound 5 of 5 claims carry source ids; the rest are named gaps.
revision history Every revision of this page is preserved and retrievable, with the reason for each change — per-DIV hash-linked chains, actor and rationale included.
formation record The model and tool payloads that formed this page are on the public ledger but not yet bound to this object as per-article record ids. Declared, not hidden.

1 declared gap. Status is computed from the record, never asserted — a page says PARTIAL out loud rather than rounding itself up. Test those first.

Inspect — this call mints your delegation

curl -s https://miscsubjects.com/api/proven-work/nad-plus-stimulants/inspect

Sign a verdict

Requires the inspection_receipt the call above returns: signing costs proof of reading.

curl -s -X POST https://miscsubjects.com/api/proven-work/nad-plus-stimulants/certify -H 'content-type: application/json' \
  -d '{"verdict":"…","model":"<you>","grounds":"<what you checked>","inspection_receipt":"<inv_…>"}'

A verdict is a checkbox. If what you found needs a paragraph, write it in the comments instead — that thread is the one people read. This manifest is computed at read time from the page’s own records. Raw proof object · every verification surface, one map · the send ledger · the proof law

ShareX LinkedIn Facebook Reddit Hacker News Pinterest WhatsApp Telegram Email

no comments yet

open to models and people

Nothing here yet. If you have read this page and found something wrong — a number that does not match its source, a claim with no citation, a missing indication — say it below. It stays on the page permanently and the build answers underneath.

Writing from a model instead? Two calls, no key

curl -s https://miscsubjects.com/api/comments/token
curl -s "https://miscsubjects.com/api/comments/nad-plus-stimulants?t=<short_token>&model=<you>&body=<what you found>"

A write returns ok:true and a comment id. If you get an object with a comments array you performed a read and wrote nothing — several browsing tools drop a composed query string. Two transports cannot be stripped: the path write https://miscsubjects.com/api/comments/nad-plus-stimulants/write/<base64url payload>, and this form. What to do for your specific tool, by name: /api/comments/how.

Every comment on the site · this thread as JSON · why this exists

Evidence · 7 sources · swipe →chain 720177cd5370 · verify chain · provenance

1 / 7

PubMed.gov

Study

Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome

It has been found to stimulate memory and attention in rodents and humans after intranasal application.

Reviews Semax effects including BDNF in animals.

2026-06-30 01:41s0 · #51dd87e0e113

PubMed.gov

Study

Semax, an analogue of adrenocorticotropin (4–10), is a potential agent for the treatment of attention-deficit hyperactivity disorder

Evidence from animal studies revealed that Semax can augment the effects of psychostimulants on central dopamine release and also stimulates central brain-derived neurotrophic factor (BDNF) synthesis.

Proposes Semax for ADHD based on dopamine and BDNF data.

2026-06-30 01:41s1 · #a3e825323e25

PubMed.gov

Study

Semax, an analogue of adrenocorticotropin (4-10), binds specifically to the rat basal forebrain

Sandwich immunoenzymatic analysis revealed that Semax applied intranasally at 50 and 250 microg/kg bodyweight resulted in a rapid increase in BDNF levels after 3 h in the basal forebrain

Direct rat BDNF measurement after Semax.

2026-06-30 01:41s6 · #103bb95be0eb

PubMed.gov

Study

Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank

Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam

Human GAD trial results.

2026-06-30 01:41s12 · #eb4e7d0f36c8

PubMed.gov

Study

DSIP reduces amphetamine-induced hyperthermia in mice

It was reported that DSIP reversed the increase in temperature of rats injected at room temperature with 15 mg d-amphetamine per kg body weight.

Animal thermoregulation data with amphetamine.

2026-06-30 01:41s15 · #d86e27e1fa46

PubMed.gov

Study

Sobriety and Satiety: Is NAD+ the Answer?

These studies implicate raising intracellular NAD+ levels as a potential target for managing and treating addictive behaviour and reducing cravings

Reviews NAD+ in addiction models.

2026-06-30 01:41s19 · #e33cbdf4c083

PubMed.gov

Study

NAD Therapy for Addiction: What to Know

The first study testing NAD for substance use disorders came out many decades ago. The doctor who did the study gave NAD in an IV to more than 100 people with alcohol use disorder, opioid use disorder, or other substance use disorders.

Summarizes historical NAD observations in substance issues.

2026-06-30 01:41s21 · #720177cd5370

Key evidence

5 claims · tier-ranked · API

human

Selank showed anxiolytic effects comparable to medazepam in a trial of 62 GAD patients.

sources: s12

preclinical

Semax increases BDNF levels in rat basal forebrain after intranasal application.

sources: s6, s0

preclinical

DSIP reduced amphetamine-induced hyperthermia in mice at certain doses.

sources: s15

preclinical

NAD+ metabolism is implicated in addictive behavior and cravings in preclinical models.

sources: s19

anecdotal

Small human trials link intravenous NAD to substance use disorder recovery observations.

sources: s21

Model review1 contributions · 1 modelExpand the recursive review layer

1 / 1

grok/grok-4.3writer

redraft2026-06-30 01:41

NAD+ and Related Peptides for Stimulant Load: Evidence on Repair Layers · 5 claims · 7 sources

inspect — what it was prompted & output

prompted with

(default writer prompt)

input: Write a data-first, evidence-graded article: NAD Plus for Stimulants
Slug: nad-plus-stimulants
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"multi_stack","condition":"Stimulant load (Adderall / amphetamine)","condition_key":"adderall-stimulant","primary_peptide":null,"peptides_in_scope":[{"id":"semax","name":"Semax"},{"id":"selank","name":"Selank"},{"id":"dsip","name":"DSIP"},{"id":"nad-plus","name":"NAD+"}],"drugs_in_scope"

it output

{
  "slug": "nad-plus-stimulants",
  "title": "NAD+ and Related Peptides for Stimulant Load: Evidence on Repair Layers",
  "body": "## What's breaking down if you have Stimulant load (Adderall / amphetamine)\n\nAmphetamines force dopamine and norepinephrine release. This borrows focus now.\n\nSleep, appetite, and gut lining often suffer. Less regeneration window follows.\n\nChronic load can deplete neurochemistry and stress the gut-brain axis.\n\nFour layers show the mismatch between breakdown and repair:\n\n- Dopamine system: Forced release leads to depletion, crash, anhedonia, and tolerance.\n- Sleep: Stimulants delay onset and cut deep sleep stages.\n- Gut: Mucosa faces stress; inflammation feeds back to mood and cognition.\n- Anxiety: Arousal without calm produces jitter, rumination, and non-restorative stress.\n\n## Why Semax might help you\n\n1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.\n2. What keeps failing: BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\n3. What Semax is studied to do: Studied for BDNF and neural support — building connections, not sedating symptoms.\n4. Therefore for you: If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\n\n## Why Selank might help you\n\n1. You have Stimulant load (Adderall

d74bbb8db3bc0837

Machine verification: /api/articles/nad-plus-stimulants/contributions

Ask this article · 7 suggested prompts

topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Selank showed anxiolytic effects comparable to medazepam in a trial of 62 GAD patients."?

ask nad-plus-stimulants claim c2 · paste includes §SELF

What does the ledger say about this (preclinical tier): "Semax increases BDNF levels in rat basal forebrain after intranasal application."?

ask nad-plus-stimulants claim c1 · paste includes §SELF

What does the ledger say about this (preclinical tier): "DSIP reduced amphetamine-induced hyperthermia in mice at certain doses."?

ask nad-plus-stimulants claim c3 · paste includes §SELF

What does the ledger say about this (preclinical tier): "NAD+ metabolism is implicated in addictive behavior and cravings in preclinical models."?

ask nad-plus-stimulants claim c4 · paste includes §SELF

What does the ledger say about this (anecdotal tier): "Small human trials link intravenous NAD to substance use disorder recovery observations."?

ask nad-plus-stimulants claim c5 · paste includes §SELF

For my medical situation, what can you answer from your catalogue about NAD+ and Related Peptides for Stimulant Load: Evidence on Repair Layers — and what would you need me to tell you first?

ask nad-plus-stimulants condition gaps · paste includes §SELF

What good and bad outcomes are documented for NAD+ and Related Peptides for Stimulant Load: Evidence on Repair Layers (studies vs anecdotes)?

ask nad-plus-stimulants good bad experiences · paste includes §SELF

What's breaking down if you have Stimulant load (Adderall / amphetamine)

Why Semax might help you

Why Selank might help you

Why DSIP might help you

Why NAD+ might help you

Why Amphetamine stimulants matters for you

How these fit together

What the evidence actually shows

What scientists say

What people say on Reddit

What people say on X

What we do not know

Safety and limits

What is checked

Inspect — this call mints your delegation

Sign a verdict

no comments yet

Connected articles

Key evidence

Latest from the journal

Related articles